NASDAQ$RGEN
Repligen Corp · Q2 2024 earnings
Q2 2024 earnings · · Investor relations
Briefing
Repligen reported solid second quarter results, achieving year-to-date sales target and demonstrating strength in Pharma demand and CDMO activity.
Repligen reported Q2 2024 revenue of $154 million, slightly below the $159 million reported in Q2 2023. The company achieved its year-to-date sales target with first-half revenue of $305 million. The company is narrowing its revenue guidance for fiscal year 2024 but adjusted EPS guidance remains unchanged.
- Second quarter revenue was reported at $154 million.
- Second quarter orders reached $157 million.
- Book-to-bill ratio was 1.02 for the quarter and 1.01 year-to-date.
- The company is narrowing revenue guidance within the previous range for fiscal year 2024, while adjusted EPS guidance remains unchanged.
Headline financials
Revenue & EPS history
Repligen · Revenue · Quarterly
$154M
Revenue by segment
Repligen · $141M total across 2 segments · Q3 2023
- Product Revenue$141M—100.0%
- Royalty and Other$36—0.0%
Forward guidance
Repligen provided financial guidance for the full year 2024, based on expectations for the existing business, including the impact of businesses acquired in 2023. The guidance excludes the impact of any potential or pending business acquisitions in 2024, and future fluctuations in foreign currency exchange rates.
Tailwinds
- Total Reported Revenue: $620M - $635M
- Gross Margin: 49% - 50%
- Income from Operations: $12M - $17M
- Operating Margin: 2% - 3%
- Adjusted EBITDA Margin: 17% - 18%
Headwinds
- Year-over-Year Change: (3%) - (1%)
- Base Revenue Growth: -(1%) - 1%
- Tax Rate on Pre-Tax Income: 35%
- Net Income: $9.5M - $13.5M
- Earnings Per Share - Diluted: $0.17 - $0.24
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2024
+2.6%
Avg return
Earnings day
+3.4%
Avg return
5 days after
+4.4%
Avg return
30 days after
59%
36 / 61 earnings
Positive
+22.1%
Q3 2018
Best reaction
-23.0%
Q3 2015
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +0.1% | -7.8% | -2.7% | |
| Q4 2025 | +1.4% | -4.9% | -15.5% | |
| Q3 2025 | -5.9% | -7.5% | +6.3% | |
| Q1 2025 | -2.9% | -1.5% | -14.8% | |
| Q4 2024 | +7.9% | +7.1% | -7.1% | |
| Q3 2024 | +7.9% | -10.6% | +11.8% | |
| Q2 2024 | +21.3% | +17.2% | +9.2% | |
| Q1 2024 | +1.3% | +2.3% | -9.2% | |
| Q4 2023 | -3.2% | -4.0% | -0.9% | |
| Q3 2023 | +15.1% | +31.7% | +37.7% | |
| Q2 2023 | +1.1% | +2.5% | +5.2% | |
| Q1 2023 | +6.4% | +4.3% | +8.8% | |
| Q4 2022 | +3.2% | -2.7% | -10.0% | |
| Q3 2022 | -6.0% | -4.5% | +3.1% | |
| Q2 2022 | +13.1% | +15.9% | +0.6% | |
| Q1 2022 | +7.8% | +11.4% | +19.3% | |
| Q4 2021 | -1.8% | -1.4% | +4.0% | |
| Q3 2021 | +7.2% | +11.7% | +5.5% | |
| Q2 2021 | +14.2% | +19.3% | +32.4% | |
| Q1 2021 | -6.4% | -9.8% | -15.6% | |
| Q4 2020 | +0.3% | +7.4% | -11.1% | |
| Q3 2020 | +8.1% | +0.0% | +0.8% | |
| Q2 2020 | +8.7% | +12.8% | +8.2% | |
| Q1 2020 | +6.7% | +11.9% | +5.0% | |
| Q4 2019 | -10.1% | -22.2% | -18.7% | |
| Q3 2019 | +9.9% | +6.1% | +15.1% | |
| Q2 2019 | -4.0% | -3.2% | -1.7% | |
| Q1 2019 | +2.5% | -0.2% | +11.5% | |
| Q4 2018 | -0.2% | +1.0% | -0.2% | |
| Q3 2018 | +22.1% | +25.2% | +19.3% | |
| Q2 2018 | -1.0% | +2.0% | +14.2% | |
| Q1 2018 | +5.1% | +10.2% | +14.9% | |
| Q4 2017 | +9.2% | +9.5% | +6.2% | |
| Q3 2017 | -7.1% | -13.0% | -4.9% | |
| Q2 2017 | +1.3% | +4.4% | +6.1% | |
| Q1 2017 | +5.2% | +6.3% | +11.7% | |
| Q4 2016 | +6.3% | +6.4% | +13.6% | |
| Q3 2016 | -4.1% | -1.1% | +10.0% | |
| Q2 2016 | -0.6% | -1.1% | +3.9% | |
| Q1 2016 | +2.1% | — | — | |
| Q4 2015 | +2.4% | — | — | |
| Q3 2015 | -23.0% | — | — | |
| Q2 2015 | -0.2% | — | — | |
| Q1 2015 | +16.9% | — | — | |
| Q4 2014 | +14.9% | — | — | |
| Q3 2014 | -6.6% | — | — | |
| Q2 2014 | -3.6% | — | — | |
| Q1 2014 | +5.0% | — | — | |
| Q4 2013 | -8.8% | — | — | |
| Q3 2013 | +8.8% | — | — | |
| Q2 2013 | -0.1% | — | — | |
| Q1 2013 | +2.9% | — | — | |
| Q3 2010 | -5.0% | — | — | |
| Q4 2012 | +5.8% | — | — | |
| Q3 2012 | +10.2% | — | — | |
| Q2 2012 | -0.4% | — | — | |
| Q4 2010 | -1.5% | — | — | |
| Q1 2012 | +0.9% | — | — | |
| Q2 2011 | -0.1% | — | — | |
| Q1 2011 | -0.9% | — | — | |
| Q4 2011 | -0.9% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro